Tscan Therapeutics
Price & Volume
Stats
See more52W Range | $1.02-$6.22 |
Market Cap | $101.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $6.9M |
Revenue Growth (YoY) | 473.9% |
Gross Profit (12 Mos) | -$8.5M |
Diluted EPS | -$1.10 |
News
See moreYahoo Finance • 7 days ago
TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
Yahoo Finance • 21 days ago
TScan Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • 3 months ago
TScan Therapeutics elects directors and ratifies auditor at annual meeting
Yahoo Finance • 4 months ago
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
About
CEO | Dr. Gavin MacBeath Ph.D. |
CFO | Mr. Jason A. Amello CPA |
Address | 830 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 208 |
